First Amendment to Amended and Restated Development and Manufacturing Agreement between EKR Therapeutics, Inc. and Baxter Healthcare Corporation

Contract Categories: Business Operations › Development Agreements
Summary

This amendment updates the notice provision in the existing Development and Manufacturing Agreement between EKR Therapeutics, Inc. and Baxter Healthcare Corporation. The change specifies a new contact and address for EKR regarding official communications. All other terms of the original agreement remain unchanged. Both parties have agreed to this amendment, which can be signed in counterparts.

View More
EX-10.1 2 d511504dex101.htm EX-10.1 EX-10.1

Exhibit 10.1

 

  Marsha G. Prokop   Baxter Healthcare Corporation
  Director, Contract Management   25212 W. Illinois Route 120 (WG2-3S)
  BioPharma Solutions   Round Lake, Illinois 60073
    Tel: 847 ###-###-####

 

July 12, 2010

EKR Therapeutics, Inc.

1545 US Highway 206, 3rd Floor

Bedminster, NJ 07921

 

Attn:   Sue Bacso
  Sr. Vice President, Operations & Supply
Re:   First Amendment to Amended and Restated Development and Manufacturing Agreement

Dear Ms. Bacso:

EKR Therapeutics, Inc. (“EKR”) and Baxter Healthcare Corporation (“Baxter”) entered into an Amended and Restated Development and Manufacturing Agreement effective November 6, 2009 (the “Original Agreement”).

The parties wish to amend Section 18.0, Notices, of the Original Agreement by deleting the fourth paragraph in its entirety and replacing it with the following:

“If to EKR:

EKR Therapeutics, Inc.

1545 US Highway 206, 3rd Floor

Bedminster, NJ 07921

Attn: Sue Bacso, Sr. Vice President, Operations & Supply

Fax: 866 ###-###-####”

Except as modified by this Amendment, the terms of the Original Agreement shall continue in full force and effect. For convenience this Amendment may be executed in counterparts with the same force and effect as if each of the signatories had executed this same instrument.

 

Very truly yours,     AGREED AND ACCEPTED:
BAXTER HEALTHCARE CORPORATION     EKR Therapeutics, Inc.

/s/ Marsha G. Prokop

     By:  

/s/ Susan Bacso

Marsha G. Prokop     Name: 7/14/2010
Director, Contract Management